AstraZeneca has announced significant reductions for medications sold in the United States, following an agreement made with the Trump administration.
Ana-Maria Tapescu
International
Foto: Formatoriginal / Alamy / Profimedia
Always see our news on Google
President Trump emphasized that, alongside reducing prices, the company will invest 50 billion USD in the USA for research and development, as well as in relocating production. This comes in the context of measures aimed at encouraging pharmaceutical laboratories to repatriate production and reduce prices.
Sources
Administraţia Trump a încheiat un acord cu AstraZeneca pentru reducerea preţului anumitor medicamente
AstraZeneca makes deal with Trump to lower drug prices and avoid tariffs
Trump reveals prescription drug deal with pharmaceutical giant AstraZeneca
AstraZeneca agrees to lower drug prices for Medicaid under Trump administration deal
Trump to announce deal with pharma giant AstraZeneca to lower drug prices, report says.
Latest News
12:11
A new star on the world map / The autonomous region of Bougainville in Papua New Guinea has overwhelmingly voted for independence
12:11
Vegetation fire in Plauru, extinguished with the help of the Army. The flames are said to have started from a drone.
12:01
The U.S. Food and Drug Administration has approved a drug that doubles the survival rate of patients with advanced pancreatic cancer.
11:31
Special Informat.ro / From backpack to after-school: the real bill of the beginning of the school year
11:25
Russia declared a Romanian embassy employee in Moscow persona non grata.
See more news
NEWS ON THE SAME TOPICS
International
AstraZeneca, negotiations with Bristol Myers Squibb for a possible merger that could create a 400 billion dollar group
International
German companies have reduced direct investments in the USA by almost two-thirds in the first half of 2026
.webp)
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
